SightStream Biotherapeutics is excited to announce that it has successfully raised $7.5 million in a recent funding round aimed at advancing its groundbreaking work in the ophthalmic space. Founded on the principle of addressing unmet medical needs, SightStream is at the forefront of developing unique regenerative and restorative therapies that target some of the most pressing challenges faced by patients with ocular disorders. The infusion of capital will be pivotal in accelerating the company’s research and development efforts, enabling it to bring transformative therapies to market more swiftly. This funding will be strategically allocated towards the enhancement of its clinical trials, expansion of its innovative product pipeline, and bolstering its research capabilities. With the burgeoning global incidence of eye-related conditions, the need for effective and novel treatment options has never been more critical. SightStream's commitment to harnessing cutting-edge science to create impactful solutions is bolstered by this investment, which establishes a robust foundation for the company's future growth and development. As the company progresses, it remains dedicated to its mission of improving patient outcomes and reshaping the landscape of ocular therapeutics. SightStream Biotherapeutics looks forward to making significant strides in the coming years, working alongside partners and stakeholders who share its vision of a world where no one has to struggle with vision impairment due to a lack of effective therapies.
Breaking Boundaries: SightStream Biotherapeutics Secures $7.5M in Series A Funding for Innovative Ophthalmic Therapies
Recently funded · $7.5M Series aHealthcare
Get the full SightStream Biotherapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
